Short-TermMedium-TermLong-TermSignals

SELLAS Life Sciences [SLS]

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Last Updated 23 Jun 2026 @ 13:33 (Exchange is open)
Last: $9.12 6.86%
0.61 (↑)
GaG Algo Score™
v1.0
Short
0.61 (↑)
Medium
2.50 (↑)
Long
1.94 (↑)
BUY
59.18%
return 32.32%
SELL
64.00%
return -26.16%

Stats

Today's Volume 4.75M
Average Volume 7.50M
Market Cap 1.22B
EPS $-0.0487 (Q1 | 2026-05-12)
Next earnings date ($-0.0500) 2026-08-11
Last Dividend $0.420 (2010-12-09)
P/E -39.63 (Sector) 26.21 (Industry) 17.28
ATR14 $0.688 (8.55%)
Possible DaySwing $7.71 - $8.39 (8.93%)

Support and Resistance Levels

Line

Pivot Data

Pivot Statistics
Metric Average Median Std Dev
Gain % 101.44% 68.84% 93.61%
Loss % -28.23% -31.06% 9.53%
Duration 26.9d 31d 12.4d
Total Pivots Found 10
Gain/Loss Legs 9 (5 Gain / 4 Loss)
Last Pivot Top @ $9.31 on 2026-05-29
Change since Last Pivot $-1.26 (-13.53%)
Next Pivot Prediction Last: $9.12
Predicted Next Type Bottom
Predicted Price (Avg) $6.68
Predicted Price (Median) $6.42
Predicted Price Range (~68%) $5.79 - $7.57
Change to Avg Target $-2.43 (-26.69%)
Predicted Date (Avg) 2026-06-24
Predicted Date Range (~68%) 2026-06-12 - 2026-07-07
Basis Based on 4 historical losses (Avg: -28.23%, Median: -31.06%, StdDev of Abs: 9.53%) and duration (Avg: 26.9 days, StdDev: 12.4 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

SELLAS Life Sciences climbs 3.74%.

SELLAS Life Sciences (SLS) stock price surged on Thursday after the stock rose $0.290 (3.74%) from the previous session on very high volume. The stock moderately outperformed the market today, rising faster than the NASDAQ's 1.91% gain. With 14.75M shares traded, volume yesterday reached $118.72M. This was 10.07M shares more than the prior day. Compared to the 10-day average of 5.98M shares, volume was more than the average.

SELLAS Life Sciences signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

SELLAS Life Sciences Support & Resistance Levels

The stock is approaching the closest resistance level at $8.33. approximately $0.280 (3.48%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $8.97. On a fall back there will be support at $5 The dis das resistance s15 -

SELLAS Life Sciences Evaluation

  • Short score: 0.61
  • Medium score: 2.50
  • Long score: 1.94